ADAR1 Capital Management’s Amicus Therapeutics FOLD Stock Holding History

ADAR1 Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-105,000	Closed	-$1.52M	–	305
2026 Q1	$1.52M	Buy	+105,000	New	+$1.51M	0.09%	133

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

ADAR1 Capital Management's FOLD Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 105,000 shares — an estimated $1.52M sold.

ADAR1 Capital Management first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $1.52M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

ADAR1 Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
ADAR1 Capital Management sold 105,000 Amicus Therapeutics shares in Q2 2026, an estimated $1.52M.
ADAR1 Capital Management first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
ADAR1 Capital Management's Amicus Therapeutics position peaked at $1.52M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.